SHENZHEN, China, Jan. 18, 2011 /PRNewswire-Asia-FirstCall/ —
Mindray Medical International Limited (NYSE:
MR), a leading developer, manufacturer and marketer of medical
devices worldwide, today announced its participation in the Arab
Health 2011, to be held from January 24-27, 2011 in Dubai,
U.A.E.
Arab Health is the most important annual medical exhibition in
the Middle East. In 2010, the event had over 2700 exhibitors
and around 66,000 visitors from more than 79 countries. This year,
Mindray will exhibit more than 50 devices from its three core
product segments: patient monitoring and life support products,
in-vitro diagnostic products and medical imaging systems. Five
important products on exhibit are described below:
Patient monitoring and life support products:
the V series Patient Monitoring System the WATO-EX 35 Anesthesia
Machine the BeneHeart D3 Defibrillator
In-Vitro diagnostic products:
the BS-800 Clinical Chemistry Analyzer the BC-6800 Auto Hematology
Analyzer
First launched in the US in the fourth quarter of 2010, the V
series platform is a modular patient monitoring system, focusing on
the philosophy of “easy-to-use” while incorporating traditionally
highly complex monitoring parameters. The system is intended for
intra hospital use under the direct supervision of a licensed
healthcare practitioner. The system architecture allows users to
customize, by removal or addition of modules, monitored parameters
based on a patient’s monitoring need or acuity level.
First introduced in China, the WATO EX-35 anesthesia machine is
suitable for general anesthesia in a wide range of patients from
infants to adults. With its stable function, advanced safety
design, reliable performance and user-friendly interface, the WATO
gives clinical users basic monitoring measurements on a color LCD
scre
‘/>”/>
SOURCE
